Higher costs headline list of new challenges faced by CROs and sponsors.
Michael Sigmund
Advertisement
Articles by Michael Sigmund
An RBM survey conducted in 2014 was repeated in 2016 in order to find out, how knowledge and practical experience with RBM have changed over that time period.
Advertisement
Latest Updated Articles
RBM—An Update of Experiences Among European CRAsPublished: October 20th 2017 | Updated:
Consequences of Brexit for Clinical Trials in EuropePublished: October 14th 2021 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
3
ACT Brief: AI-Enabled Workflow Automation, Subcutaneous Lunsumio VELO Approval, and Pan-KRAS Early-Stage Development
4
Applying AI to Automate Workflows Without Disrupting Sites
5